ARCHIVES

PRI Fires Gilden, Compten, Sues For $1 Million By May Be Out Of Recompetition; NCI Is “Neutral”

This article is from The Cancer Letter archive.

Vol. 12 No. 32 | August 8, 1986

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities.

May 24, 2002

In Brief: IOM Cancer Policy Forum names six at-large members

August 1, 2014

Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says

October 29, 1999

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

Guidelines Adopted For Pathology Review

February 22, 1980

Lung Cancer Survivors Claim Good QOL, Despite Challenges

August 30, 2002